Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2012
03/15/2012US20120064078 Novel Tumor Biomarket
03/15/2012US20120064077 Stable and soluble antibodies inhibiting tnf alpha
03/15/2012US20120064076 Methods and composition to regulate iron metabolism
03/15/2012US20120064075 Chimeric factor vii molecules with enhanced half life and methods of use
03/15/2012US20120064074 Antigen binding domains
03/15/2012US20120064073 Il-17 homologous polypeptides and therapeutic uses thereof
03/15/2012US20120064072 Combination Cancer Therapy Comprising Administration of an EGFR Inhibitor and an IGF-1R Inhibitor
03/15/2012US20120064071 Treatment of cancer
03/15/2012US20120064070 Modulation of nkg2d
03/15/2012US20120064069 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064068 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064067 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064066 Monoclonal Antibodies to Hepatocyte Growth Factor
03/15/2012US20120064065 Safe and functional humanized antibodies
03/15/2012US20120064064 Antigen-binding proteins
03/15/2012US20120064063 Compositions of F(ab')2 Antibody Fragments
03/15/2012US20120064062 Inhibitors of bacterial plasminogen activators
03/15/2012US20120064061 Adhesive composition comprising tannin, poly(ethylene glycol), and water, lower alcohol or mixture thereof
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
03/15/2012US20120064037 Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids
03/15/2012US20120064036 Methods of Administration of Thrombopoietin Agonist Compounds
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012US20120064010 CCR3 and its Ligands Are Therapeutic and Diagnostic Targets for Neovascular Age-Related Macular Degeneration
03/15/2012US20120064001 Anti-VEGF Antibody Compositions and Methods
03/15/2012US20120064000 Human Monoclonal Antibodies Against Hendra And Nipah Viruses
03/15/2012US20120063999 Psca: prostate stem cell antigen and uses thereof
03/15/2012US20120063998 Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody
03/15/2012US20120063997 Delivery system with scaffolds
03/15/2012US20120063995 Non-ad5 adenoviral vectors and methods and uses related thereto
03/15/2012US20120063994 Rtef-1 variants and uses thereof
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012CA2811056A1 Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
03/15/2012CA2810971A1 Developments in meningococcal outer membrane vesicles
03/15/2012CA2810636A1 Ttll4 peptides and vaccines containing the same
03/15/2012CA2810632A1 Use of anti third party central memory t cells for anti-leukemia/lymphoma treatment
03/15/2012CA2810603A1 Immunogenic composition comprising neisseria menigitidis macrophage infectivity potentiator protein
03/15/2012CA2810359A1 4-1bb binding molecules
03/15/2012CA2810281A1 Vaccine against n. meningitidis
03/15/2012CA2809758A1 Non-lipidated variants of neisseria meningitidis orf2086 antigens
03/15/2012CA2714880A1 A novel tumor biomarker
03/14/2012EP2428800A1 Pharmaceutical compositions and methods to vaccinate against mucosal candidiasis
03/14/2012EP2428522A1 Antibodies that bind to PSCA proteins for diagnosis of cancer
03/14/2012EP2428252A1 Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
03/14/2012EP2428226A1 Antibody targeting compounds
03/14/2012EP2428225A2 Use of human cells of myeloid leukaemia origin for expression of antibodies
03/14/2012EP2428224A2 Use of human cells of myeloid leukaemia origin for expression of antibodies
03/14/2012EP2428223A2 Use of human cells of myeloid leukaemia origin for expression of antibodies
03/14/2012EP2428222A2 Vaccine peptide combinations against cat allergy
03/14/2012EP2428221A1 Dengue vaccine, pharmaceutical composition comprising the same, nucleotide molecule and antibody composition
03/14/2012EP2428220A1 Dengue vaccine, pharmaceutical composition comprising the same, and nucleotide molecule
03/14/2012EP2428219A1 Methods for the treatment or prevention of autoimmune diseases or autoinflammatory diseases
03/14/2012EP2428216A2 Methods of treating cancer using IL-21 and monoclonal antibody therapy
03/14/2012EP2427547A1 Method for producing virus from cell culture involving homogenization
03/14/2012EP2427496A1 Anti-vegf-d antibodies
03/14/2012EP2427493A1 Humanized anti-egfl7 antibodies and methods using same
03/14/2012EP2427491A2 Compositions and methods for antibodies targeting complement protein c3b
03/14/2012EP2427485A2 Cd133 epitopes
03/14/2012EP2427479A2 Antibodies and methods of use thereof
03/14/2012EP2427213A2 Alpha thymosin peptides as vaccine enhancers
03/14/2012EP2427212A2 Anti-cd100 antibodies and methods for using the same
03/14/2012EP2427211A1 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
03/14/2012EP2427210A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb)
03/14/2012EP2427209A1 Anti-il1- antibody combination therapy
03/14/2012EP2427189A1 S1p3 receptor inhibitors for treating conditions of the eye
03/14/2012EP2203184B1 Vaccine composition for the prevention of cmv infections
03/14/2012EP1910837B1 Methods and compositions for diagnosis and treatment of influenza
03/14/2012EP1869085B1 Novel anti-plgf antibody
03/14/2012EP1707215B1 Remedy for vasculitis
03/14/2012EP1613658B1 Antibodies against insulin-like growth factor i receptor and uses thereof
03/14/2012EP1572946B1 Therapeutic human anti-il-1r1 monoclonal antibody
03/14/2012EP1546194B1 Therapeutic uspa1-derived peptides
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1448984B1 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens
03/14/2012EP1436003B3 Taci-immunoglobulin fusion proteins
03/14/2012EP1416958B2 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
03/14/2012CN1976951B Anti-EpCAM immunoglobulins
03/14/2012CN1558774B Angiotensin peptide-carrier conjugates and uses thereof
03/14/2012CN102378814A Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
03/14/2012CN102378767A Anti-fgfr3 antibodies and methods using same
03/14/2012CN102378634A Methods for pancreatic tissue regeneration
03/14/2012CN102378633A Immunologic adjuvant composition and use thereof
03/14/2012CN102373215A Antigen binding molecules with increased fc receptor binding affinity and effector function
03/14/2012CN102373214A Antigen binding molecules with increased fc receptor binding affinity and effector function
03/14/2012CN102373184A Avian influenza and infectious bronchitis hybrid virus-like particle as well as preparation method and application thereof
03/14/2012CN102373183A Mixed virus-like particle (VLP) of avian influenza and Newcastle disease, preparation method thereof and application thereof
03/14/2012CN102373182A Mixed virus-like particle (VLP) of avian influenza and infectious bursal disease, preparation method thereof and application thereof
03/14/2012CN102373181A Swine influenza virus-porcine reproductive and respiratory syndrome virus mixed virus-like particle, and its preparation method and use
03/14/2012CN102373180A Recombinant duck enteritis virus (DEV) vaccine strain for expressing avian influenza virus haemagglutinin (HA) gene and constructing method and application thereof
03/14/2012CN102372779A Camel single domain antibody with allinase activity as well as preparation method and application thereof
03/14/2012CN102372778A Anti-human VEGF/anti-OPN bispecific antibody, its preparation method and application
03/14/2012CN102372773A Human bladder cancer tumor marker, antibody thereof and application thereof
03/14/2012CN102372766A O-type foot-and-mouth disease multi-epitope vaccine with cross immunity protective efficiency
03/14/2012CN102370988A Technology for transferring antitumor medicament with single-wall carbon nanotube and application thereof
03/14/2012CN102370981A Reagent and method for preventing and treating neurodegenerative diseases
03/14/2012CN102370979A Building method for autovaccine by aiming at human TNF(Tumor Necrosis Factor)-alpha molecule
03/14/2012CN102370978A Thermosensitive hepatitis B vaccine
03/14/2012CN102370977A Novel vaccine adjuvant and application
03/14/2012CN102370976A Mixed virus-like particles of swine influenza virus and foot and mouth disease virus, preparation method and application thereof
03/14/2012CN102370975A Preparation method of vaccine for Edwardsiellosis of Ictalurus punctatus
03/14/2012CN102370974A Yeast-based vaccines as immunotherapy
1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 1823